Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-034825
Filing Date
2025-11-13
Accepted
2025-11-13 16:11:15
Documents
99
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q aytu20250930_10q.htm   iXBRL 10-Q 1191757
2 EXHIBIT 31.1 ex_864168.htm EX-31.1 13589
3 EXHIBIT 31.2 ex_864169.htm EX-31.2 13588
4 EXHIBIT 32.1 ex_864170.htm EX-32.1 8575
10 aytu20231231_10qimg001.jpg GRAPHIC 2569
  Complete submission text file 0001437749-25-034825.txt   7956432

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA aytu-20250930.xsd EX-101.SCH 85939
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aytu-20250930_cal.xml EX-101.CAL 63150
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aytu-20250930_def.xml EX-101.DEF 534170
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE aytu-20250930_lab.xml EX-101.LAB 482461
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aytu-20250930_pre.xml EX-101.PRE 586461
102 EXTRACTED XBRL INSTANCE DOCUMENT aytu20250930_10q_htm.xml XML 1274637
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38247 | Film No.: 251478558
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)